Latest Developments in Global Citrullinemia Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Citrullinemia Market

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In November 2022, Food Specialities Limited (FSL), in collaboration with prominent international food ingredient solution providers, presented a range of innovative products and award-winning technologies at Gulfood Manufacturing. Among these was a selection of four new micronutrient premixes from SternVitamin, Germany, aimed at enhancing the nutritional profile of food and beverages. A highlight of the presentation was SternEnergize, a scientifically formulated premix designed for pre-workout consumption. This product combines vitamins, minerals, branched-chain amino acids, L-taurine, L-citrulline, L-arginine, and natural caffeine to provide a comprehensive boost for workout preparation
  • In August 2022, the FDA granted rare pediatric disease designation to iECURE’s gene-editing therapy, GTP-506, which is being investigated as a potential treatment for Ornithine Transcarbamylase (OTC) deficiency. This therapy, along with other programs from iECURE, is being developed in collaboration with the University of Pennsylvania’s Gene Therapy Program under the leadership of Dr. James M. Wilson. The initial pipeline also includes programs targeting Citrullinemia Type 1 and phenylketonuria
  • In January 2021, Taiho Convenience Stores Co., Ltd. introduced Rismitas, a functional food product designed to alleviate the common issue of cold hands, particularly among women. This product, believed to be effective in maintaining warmth in the hands, focuses on the back of the hands and wrists during colder weather, offering comfort to individuals suffering from this discomfort